Clinical Accelerator
Clinical Accelerator conducts all phases of clinical trials for pharma, biotech and medtech companies.
We have a very simple mission: to accelerate clinical development projects and to reduce their cost appreciably for our clients.
We are specialists in effective and timely patient recruitment, and commit to achieving patient enrolment targets within fixed timelines.
We routinely rescue stalled clinical trials.
The cost of our studies is among the most attractive globally. We commit to our budgets and fix them for our clients.
Contact Clinical Accelerator via their website
News archive
25/09/2018 Temple Therapeutics BV Publishes Evitar™data: study conducted by Clinical Accelerator...more
17/09/2018 Clinical Accelerator announces collaboration with Oncolix...more
03/08/2018 VisCardia Inc. announces commencement of Clinical Accelerator pilot study in Ukraine...more
16/07/2018 Clinical Accelerator reports high quality trial data for Central and Eastern Europe...more
12/06/2018 Clinical Accelerator reports ARREST Phase IIb study results...more
03/05/2018 Noxopharm announces start of DARRT-1 clinical study conducted by Clinical Accelerator...more
17/04/2018 Replicor presents long-term data from study conducted by Clinical Accelerator...more
11/12/2017 Clinical Accelerator announces collaboration with VisCardia...more
28/02/2017 Clinical Accelerator forms ClinAccel.Net...more
05/05/2016 Clinical Accelerator to Exhibit at Bio International 2016...more
04/05/2016 Clinical Accelerator Annouce Collaboration With Galmed...more
10/11/2014 Clinical Accelerator joins the BioPartner Programme...more
